(Q40423855)

20 September 2017

1 reference

title

The role of interferon-alpha as a modulator of fluorouracil and leucovorin (English)

1 reference

20 September 2017

The role of interferon-α as a modulator of fluorouracil and leucovorin (English)

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

19 May 2024

1 reference

5

Alexander HR

1 reference

20 September 2017

J. L. Grem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577043

19 May 2024

C. J. van Groeningen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577043

19 May 2024

A. A. Ismail

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577043

19 May 2024

P. G. Johnston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577043

19 May 2024

C. J. Allegra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577043

19 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7577043

19 May 2024

publication date

1 July 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:095980499591267G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

https://api.elsevier.com/content/article/PII:095980499591267G?httpAccept=text/plain

19 May 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

European Journal of Cancer

19 May 2024

published in

1 reference

20 September 2017

volume

31A

1 reference

20 September 2017

issue

7-8

1 reference

20 September 2017

page(s)

1316-1320

1 reference

Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Interferon effects upon fluorouracil metabolism by HL-60 cells

19 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects

19 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells

19 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase

19 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.

19 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma

19 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Interaction between 5-fluorouracil, [6RS]leucovorin, and recombinant human interferon-alpha 2a in cultured colon adenocarcinoma cells

19 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Determinants of trimetrexate lethality in human colon cancer cells

19 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil

19 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid

19 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Cytokinetic effects of interferon in colorectal cancer tumors: implications in the design of the interferon/5-fluorouracil combinations

19 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma

19 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma

19 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue

19 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a

19 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

19 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer

19 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil

19 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Influence of different doses of interferon-alpha-2b on the blood plasma levels of 5-fluorouracil

19 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation

19 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferon

19 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)91267-G

19 May 2024

Identifiers

1 reference

20 September 2017

1 reference